Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITAL study of paricalcitol for reduction of albuminuria in type 2 diabetic nephropathy
2006-001363-31Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic glomerulosclerosis and chronic kidney disease (CKD) comparing Paricalcitol with Placebo (2 arms). Started Mar 2007; status: completed.
02
Drugs
paricalcitol
03
Conditions
diabetic glomerulosclerosischronic kidney disease (CKD)
Beyond the preview
Go deeper on 2006-001363-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001363-31.